Skip to main content

letter

. 1974 Feb;1(1):86–87. doi: 10.1111/j.1365-2125.1974.tb00214.x

The renal excretion of mexiletine (Kö 1173) under controlled conditions of urine pH

Moira A Kiddie, C M Kaye

PMCID: PMC1402406 PMID: 22454877

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BECKETT A. H., ROWLAND M. RHYTHMIC URINARY EXCRETION OF AMPHETAMINE IN MAN. Nature. 1964 Dec 19;204:1203–1204. doi: 10.1038/2041203a0. [DOI] [PubMed] [Google Scholar]
Beckett A. H., Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965 Oct;17(10):628–639. doi: 10.1111/j.2042-7158.1965.tb07575.x. [DOI] [PubMed] [Google Scholar]
Campbell N. P., Kelly J. G., Shanks R. G., Chaturvedi N. C., Strong J. E., Pantridge J. F. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet. 1973 Aug 25;2(7826):404–407. doi: 10.1016/s0140-6736(73)92271-x. [DOI] [PubMed] [Google Scholar]
Kelly J. G., Nimmo J., Rae R., Shanks R. G., Prescott L. F. Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol. 1973 Jul;25(7):550–553. doi: 10.1111/j.2042-7158.1973.tb09155.x. [DOI] [PubMed] [Google Scholar]
Kiddie M. A., Royds R. B., Shaw T. R. Preliminary studies on the pharmacology of an antidysrhythmic, Kö 1173, in man. Br J Pharmacol. 1973 Mar;47(3):674P–675P. [PMC free article] [PubMed] [Google Scholar]
Talbot R. G., Nimmo J., Julian D. G., Clark R. A., Neilson J. M., Prescott L. F. Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet. 1973 Aug 25;2(7826):399–404. doi: 10.1016/s0140-6736(73)92270-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES